InvestorsHub Logo
Followers 120
Posts 20756
Boards Moderated 0
Alias Born 06/13/2011

Re: ggwpq post# 373626

Tuesday, 03/22/2022 7:07:40 PM

Tuesday, March 22, 2022 7:07:40 PM

Post# of 426504
Well there’s the issue of patents and markets
The PCSK9.. Inclirisan… is patent protected in both EU and US markets plus ROW
It’s not really a statin add on … its promise is as a better option to statin therapy

The idea behind Inclirisan is that its 2 shots a year to basically cut your LDL cholesterol in half
One shot when U get your annual flu shot and another 6 mths later in a clinic

Problem right now is cost
The first year you need 3 shots priced at around $3K each . Then following years is 2 shots …. $6k a year
That WAC cost to the insurer

My Repatha is roughly $100 a month to me ..but I have to self inject it every 2 weeks … sub Q

Current view is that NVS over paid for Inclirisan. Launch was delayed in the US and most insurers are refusing to cover I think based on cost

On a more upbeat note
Kaiser just sent me another 400 caps of Brand Vascepa for $24 … their retail price is just over $1,000 for the same number of caps
100 days of V ( 4 caps a day ) for $24
What’s that ….24 c a day ?
Chk my math …I’m having a beer to celebrate:—)

Kiwi
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News